Predictors and Prognostic Factors of Myasthenia Gravis Outcome
Recruiting
Observational Study
Myasthenia Gravis
Autoimmune Diseases of the Nervous System
Neuromuscular Junction Diseases
Thymoma
Thymus Hyperplasia
Nervous System Diseases
Myasthenia Gravis, Generalized
Myasthenia Gravis, Ocular
Myasthenia Gravis Crisis
Myasthenia Gravis With Exacerbation (Disorder)
Myasthenia Gravis, Adult Form
Myasthenia Gravis, Juvenile Form
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 16 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 30 (estimated)
- Sponsor
- Assiut University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to characterize the clinical features, frequency of different subgroups of MG, and identify predictors of treatment responsiveness among different subgroups of MG. The predictors are including primary outcome (percentage of changes in MG scales at baseline at time of enrollment and after 3 months) and secondary outcome (treatment-related adverse events). Also it aims to determine t…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Age from 16 years and older.
2. Gender: both sexes are included.
3. Clinical Diagnosis of MG with supporting evidence as:
1. unequivocal clinical response to pyridostigmine
2. decrement \>10% in repetitive nerve stimulations study (RNS).
4. Willingness to sample collec…
Contacts